| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 09/18/2008 | US20080227738 Compositions and methods for cell dedifferentiation and tissue regeneration |
| 09/18/2008 | US20080227737 Comprises nucleotide sequences for use as diagnostic tools in identifying allelic sequences associated with blood sugar defects |
| 09/18/2008 | US20080227736 Used to transduce heterologous genes into a cell and can be used for in vivo and ex vivo therapeutic applications, as well as for diagnostic and research tool applications |
| 09/18/2008 | US20080227734 Mutant Lrp5/6 Wnt-Signaling Receptors in Cancer Diagnosis, Prognosis, and Treatment |
| 09/18/2008 | US20080227711 Cxc-Chemokine Antagonists |
| 09/18/2008 | US20080227706 Polypeptides and polynucleotides; genetic engineering; medical diagnosis; treatment of infection causes sepsis, meningitis, pneumonia, cellulitis, osteomyelitis, septic arthritis, endocarditis or epiglottis; bacterial protein antigen vaccine |
| 09/18/2008 | US20080227705 Apoptosis-inducing agent and method for inducing apoptosis |
| 09/18/2008 | US20080227704 CXCL13 binding proteins |
| 09/18/2008 | US20080227703 neublastin neurotrophic factor polypeptides for treating neuropathy |
| 09/18/2008 | US20080227699 Therapeutic Agent for Neurodegenerative Diseases |
| 09/18/2008 | US20080227698 oligopeptide antagonizes binding of DKK1 to LRP5 when in contact with LRP5; degenerative bone diseases |
| 09/18/2008 | US20080227695 reduced expression and/or function of Dlg (discs large) is an important factor for tumor formation; measuring the expression and/or function of Dlg |
| 09/18/2008 | US20080227639 non-coding regulatory element polynucleotide molecules isolated from the Metallothionein gene of Oryza sativa and useful for expressing transgenes in plants. The invention further discloses compositions, polynucleotide constructs, transformed host cells, transgenic plants and seeds containing Oryza |
| 09/18/2008 | US20080227204 Nutrient broth comprising fibronectin and CD-3 specific antibody for use as inductive source for propagation of natural killer cells |
| 09/18/2008 | US20080227203 Preparing thin film comprising immobilized temperature responsive polymer via y-ray irradiation; substrate for propagating cell sheets |
| 09/18/2008 | US20080227202 Using progenitior cell tissues to propagate human hybrid hemodialysis access grafts; tissue engineering and repair; regenerative medicine |
| 09/18/2008 | US20080227201 In vitro model for neuronal death |
| 09/18/2008 | US20080227200 Polypeptide having an activity to support proliferation or survival of hematopoietic stem cell and hematopoietic progenitor cell, and DNA coding for the same |
| 09/18/2008 | US20080227199 Method for simultaneous production of multiple proteins; vectors and cells for use therein |
| 09/18/2008 | US20080227198 Using anti-CD80 antibody to induce lymphocyte response which targets B cell malignancies |
| 09/18/2008 | US20080227197 Allogeneic stem cell bank |
| 09/18/2008 | US20080227196 Mammalian cells defective in 1,6-fucosyltransferase activity for generating antibodies which target tumor cells |
| 09/18/2008 | US20080227195 Expanding the eukaryotic genetic code |
| 09/18/2008 | US20080227194 Lipolytic enzyme specific antibody for use in diagnosis of pancreatitis |
| 09/18/2008 | US20080227193 Expression vector coding oxidoreductase for use in identifying modulators which prevent parasitic worm infection; nematocides; biological pest control |
| 09/18/2008 | US20080227192 Nematode ATP Synthase Subunit E-Like Sequences |
| 09/18/2008 | US20080227168 Methods and materials for extra and intracellular delivery of carbon nanotubes |
| 09/18/2008 | US20080227158 Novel polypeptide, novel dna and novel antibody |
| 09/18/2008 | US20080227156 Nucleotide sequences coding myostatin epitopes for use in treatment and prevention of diabetic disorders; immunotherapy |
| 09/18/2008 | US20080227155 Pegylated soluble gp130-dimers useful as a medicament |
| 09/18/2008 | US20080227154 Protein Expression |
| 09/18/2008 | US20080227152 In vivo incorporation of unnatural amino acids |
| 09/18/2008 | US20080227151 Method for simultaneous production of multiple proteins; vectors and cells for use therein |
| 09/18/2008 | US20080227149 Interferon-Alpha Polypeptides and Conjugates |
| 09/18/2008 | US20080227146 Immortalized Avian Cell Lines For Virus Production |
| 09/18/2008 | US20080227140 Fluorescence resonance energy transfer; autoimmune disorders; immunosuppression; drug screening |
| 09/18/2008 | US20080227137 Differentiation of primate embryonic stem cells into nervous system tissue; obtain primate embryonic stem cell, propagate in culture containing fibroblast growth factor, recover cells |
| 09/18/2008 | US20080227136 Cell culture improvements |
| 09/18/2008 | US20080227133 Recombinant klebsiella cleaving enzyme (Kpn1) for use as non-specialized gene cutting tool; gel electrophoresis; point mutations; site-directed mutagenesis |
| 09/18/2008 | US20080227131 P38 mitogen activated protein kinase fusion for use as reporter molecule in enzyme activation bioassays |
| 09/18/2008 | US20080227129 Using multimeric ubiquitin fusion protein as an enzyme activity indicator; destruction of reporter demonstrate enhanced enzyme activity |
| 09/18/2008 | US20080227127 Human NK3-Related Prostate Specific Gene-1 |
| 09/18/2008 | US20080227123 Methods for Specifically Selecting Antibody-Producing Cells |
| 09/18/2008 | US20080227122 P2y purinergic receptor expression for identifying preneoplastic and neoplastic states |
| 09/18/2008 | US20080227119 ELISA for VEGF |
| 09/18/2008 | US20080227113 Lipocalin-type prostaglandin D2 synthase specific monoclonal antibody for use in diagnosis of nervous system trauma and dysfunction |
| 09/18/2008 | US20080227110 Expression vector comprising nucleotide sequences coding human polypeptide for use in treatment of metabolic disorders; immunotherapy |
| 09/18/2008 | US20080227082 Method of identifying a mhc class i restricted t cell response |
| 09/18/2008 | US20080226726 Drug mixture containing biodegradable gel, active materials and stem cells which differentiate into heart tissue in form of patch |
| 09/18/2008 | US20080226692 Cultured Cell Sheet, Production Method Thereof, and Application Method Thereof |
| 09/18/2008 | US20080226675 Supplying genes to human cells; gene expression blocks; mutant lentivirus vectors; prevention, therapy aids |
| 09/18/2008 | US20080226666 Immunogenic polypeptide for protecting pigs against viral infection or postweaning multisystemic wasting syndrome |
| 09/18/2008 | US20080226664 Colon cancer antigen panel |
| 09/18/2008 | US20080226663 Pine Cone Extracts and Uses Thereof |
| 09/18/2008 | US20080226662 Nucleotide sequences coding mammalian immune system modulator (B7-DC) for use in treatment and prevention of viral infcetion a nd cell proliferative disorders; immunotherapy |
| 09/18/2008 | US20080226654 Uses of mammalian cytokine; related reagents |
| 09/18/2008 | US20080226650 Cotinine neutralizing antibody |
| 09/18/2008 | US20080226647 Using interferon gamma receptor 1 (IFNGR1) specific immunoglobulin for diagnosis, prevention and treatment of myxovirus infection |
| 09/18/2008 | US20080226646 Use of biomolecular targets in the treatment and visualization of tumors |
| 09/18/2008 | US20080226643 Compositions and methods for the therapy and diagnosis of breast cancer |
| 09/18/2008 | US20080226642 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 09/18/2008 | US20080226641 Mixture comprising group B streptococcal peptide for use in generating vaccine and immunoglobulins for diagnosis, prevention and treatment of urinary tract infections |
| 09/18/2008 | US20080226637 Hemophilus polypeptide for generating immunoglobulins and vaccines for use in prevention and treatment of bacterial infection |
| 09/18/2008 | US20080226636 Novel human ulip/CRMP protein and use thereof in diagnosis and treatment of cancers and paraneoplastic neurological syndromes |
| 09/18/2008 | US20080226635 Transmembrane receptor specific immunoglobulin for use in targeting and destroying pancreatic, lung and/or breast cancers |
| 09/18/2008 | US20080226633 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 09/18/2008 | US20080226632 Cell growth factor specific immunoglobulin for treatment and prevention of cell proliferative and skin disorders |
| 09/18/2008 | US20080226631 Methods of modulating cytokine activity; related reagents |
| 09/18/2008 | US20080226630 Recombinant antibodies for treatment of respiratory syncytial virus infections |
| 09/18/2008 | US20080226628 CDR-Grafted Anti-Tissue Factor Antibodies and Methods of Use Thereof |
| 09/18/2008 | US20080226627 Using clostridium botulinum neurotoxin complex (Hn-33) protein as diagnostic tool in identifying modulators for treatment and prevention of clostridial poisoning; antitumor agents |
| 09/18/2008 | US20080226622 Hypoxia inducible factor (Hif); for modulating mRNA translation within cells; prevents excessive vascularization |
| 09/18/2008 | US20080226621 Antagonist anti-notch3 antibodies and their use in the prevention and treatment of notch3-related diseases |
| 09/18/2008 | US20080226620 Polypeptide comprising major histocompatibility complex epitopes for use in targeting and destroying tumor cells |
| 09/18/2008 | US20080226619 Anti-Muc1 Alpha/Beta Antibodies |
| 09/18/2008 | US20080226612 Compositions of Cells Enriched for Combinations of Various Stem and Progenitor Cell Populations, Methods of Use Thereof and Methods of Private Banking Thereof |
| 09/18/2008 | US20080226611 Using vector transformation to generate transgenic connective tissues for use in treatment of degenerative joint diseases |
| 09/18/2008 | US20080226610 Expression vector comprising nucleotide sequences coding syncytium-inducing polypeptide for use in targeting tumor cells for destruction; antitumor agents |
| 09/18/2008 | US20080226609 Transplantation of Glial Restricted Precursor-Derived Astrocytes for Promotion of Axon Growth |
| 09/18/2008 | US20080226608 Methods of Isolating and Using Enriched Subpopulations of Bone Marrow Progenitors for the Treatment of Diabetes |
| 09/18/2008 | US20080226607 Polypeptide comprising major histocompatibility complex epitopes for use in targeting and destroying tumor cells |
| 09/18/2008 | US20080226606 Polypeptide comprising major histocompatibility complex epitopes for use in targeting and destroying tumor cells |
| 09/18/2008 | US20080226605 Methods and Compositions Facilitating Entry of Compounds Into Cells |
| 09/18/2008 | US20080226604 Methods for treating ischemic tissue |
| 09/18/2008 | US20080226600 Adeno-associated viruses and uses thereof |
| 09/18/2008 | US20080226598 Dendritc specific RNA viral plasmid comprising nucleotide sequences coding tumor associated for use in developing cancer vaccine; genetic vaccines |
| 09/18/2008 | US20080226597 Viricidal protein for prevention and treatment of hepatitis infection |
| 09/18/2008 | US20080226595 Using placental stem cell inoculation comprising anti-inflammatory, inteferon and/or immunosuppressant supplements as therapeutic in treatment of cell proliferative and inflammatory disorders |
| 09/18/2008 | US20080226587 Methods and compositions for immunomodulation |
| 09/18/2008 | US20080226560 Supplying cargo compound into cancer cells; cargo compound may be nucleic acids, Dna, Rna |
| 09/18/2008 | US20080226558 Mesoderm and definitive endoderm cell populations |
| 09/18/2008 | US20080226549 Diagnosing cancer; measuring antibody inhibition; calibration; reduced concentration of inhibitor indicates cancer receptivity |
| 09/18/2008 | DE102007012645A1 Substituierte Imidazo- und Triazolopyrimidine Substituted imidazo and triazolopyrimidines |
| 09/18/2008 | CA2821430A1 Dominant gene suppression transgenes and methods of using same |
| 09/18/2008 | CA2688121A1 Markers, antibodies and recombinant scfvs for mesenchymal stem cell-sub-populations and osteoclasts |
| 09/18/2008 | CA2680792A1 Treatment of autoimmune disorders |
| 09/18/2008 | CA2680742A1 Improving cold- and salt-tolerant performance of plants with transcription factor gene snac2 from rice |
| 09/18/2008 | CA2680600A1 Li-rnai involved li suppression in cancer immunotherapy |
| 09/18/2008 | CA2680162A1 Methods and compositions for growth of embryonic stem cells |
| 09/18/2008 | CA2658612A1 Antibodies directed to .alpha.v.beta.6 and uses thereof |